STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
105
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $0 priced
What the filings say about BEKE
Insiders, 180 days
-$102.6M net sold
2 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$107.6M
2 notices
KE insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, KE Holdings Inc. insiders sold a net $102.6M of stock across 2 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
Foreign private issuer: most of its insiders are exempt from SEC Form 4, but some still file it; those filings are listed below, and the record may be incomplete.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 25.5% of the 62,824,251 shares held after it.
1 other insider sold within 30 days.
105 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Executive Officer Peng Yongdong sold about $84.6M of BEKE on Sep 25, 2026, the largest insider sale at the company on our record; 1 other insider sold within 30 days and 105 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 6.2% of the 53,868,189 shares held after it.
1 other insider sold within 30 days.
105 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Executive Director Shan Yigang sold about $18.1M of BEKE on Sep 21, 2026, the largest insider sale at the company on our record; 1 other insider sold within 30 days and 105 funds added in the latest 13F quarter.
2 transactions on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
BEKE planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Ever Orient International Limited
Filed 2026-09-25
$89.2M
Clover Rich Limited
Filed 2026-09-21
$18.4M
BEKE mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Baird Chautauqua International Growth Fund
$43.2M position · as of 2026-06-30
3.3%
ULTRACHINA PROFUND
$578.7K position · as of 2026-07-31
2.8%
Davis International Fund
$7.2M position · as of 2026-07-31
2.7%
PROFUND VP ASIA 30
$579.4K position · as of 2026-06-30
2.6%
Davis Select International ETF
$6.7M position · as of 2026-07-31
2.3%
Invesco Golden Dragon China ETF
$2.2M position · as of 2026-07-31
2.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $102.6M sold by insiders over 180 days, 105 funds added last quarter, $107.6M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM BEKE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM BEKE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
fewer than four consecutive quarters of operating cash flow
Free cash flow, TTM BEKE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Single quarter
Debt to equity
0.01x
long-term 2025-12-31 plus current 2024-12-31; equity 2025-12-31
Debt to equity BEKE
FY Dec 2025
0.01x
FY Dec 2024
0.00x
FY Dec 2023
0.00x
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
needs four quarters of operating cash flow
Cash flow to debt BEKE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
fewer than four consecutive quarters of net income
Return on equity BEKE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
n/a
fewer than four consecutive quarters of net income
Return on assets BEKE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital BEKE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed BEKE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing BEKE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value BEKE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield BEKE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing BEKE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
BEKE ranks highest on financial health (94th percentile) and risk and compliance (64th), and lowest on insider conviction (1st), among Real Estate peers.
Financial health
94
Inputs
Debt to equity0.01x · 94 pct, sector of 210
Cash flow to debtneeds four quarters of operating cash flow
Growth
47
Inputs
Revenue growth, YoY+5.6% · 56 pct, sector of 244
Backlog growth, YoY-3.2% · 37 pct, universe of 854
Insider conviction
0
Inputs
Net Form 4 buying (codes P and S), 180d-$102.6M · 1 pct, sector of 156
Insider buyers, 180d0 · 0 pct, sector of 158
Institutional and government
43
Inputs
Funds adding, latest quarter105 · 43 pct, sector of 171
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
64
Inputs
Short interest, % of float+3.2% · 64 pct, sector of 256
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
2 not measured: Profitability, US patents
Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
BEKE filings, in plain words
Are KE insiders buying or selling BEKE?
In the 180 days to 2026-10-27, KE insiders were net sellers, a net $102.6M across purchases and sales reported on Form 4, by 2 sellers.
Are there planned insider sales of BEKE?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $107.6M of stock; the latest, by Ever Orient International Limited, was filed 2026-09-25.
Read the full summary
In the 180 days to 2026-10-27, KE insiders were net sellers of BEKE, a net $102.6M across purchases and sales reported on Form 4 by 2 sellers. Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $107.6M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.